Education
About Us
Working with TipRanks
Follow Us
Connect Biopharma Holdings Ltd. (CNTB)
:CNTB
CNTB Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CNTB Stock 12 Month Forecast
Average Price Target
$6.83
▲(217.67% Upside)
| Highest Price Target$7.50 | Average Price Target$6.83 | Lowest Price Target$6.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
$6
Buy
179.07%
Upside
Reiterated
08/14/25
H.C. Wainwright
$7
Buy
225.58%
Upside
Reiterated
08/13/25
Promising Developments and Strategic Moves Justify Buy Rating for Connect Biopharma HoldingsValuation and Risks. We base our valuation on our probability-weighted clinical net present value (NPV) discounted cash flow valuation model. We use a weighted average cost of capital of 16.2% in our discounted cash flow, and an exit multiple of 10.0x our 2036 estimates.Our peak sales estimates assume a 55% probability of success for rademikibart in acute exacerbations in the 15% probability of success for rademikibart in the EU.
Northland Securities
$7.5
Buy
248.84%
Upside
Initiated
07/22/25
TR | OpenAI - 4o
―
Hold
―
Reiterated
04/26/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
$6
Buy
179.07%
Upside
Reiterated
08/14/25
H.C. Wainwright
$7
Buy
225.58%
Upside
Reiterated
08/13/25
Promising Developments and Strategic Moves Justify Buy Rating for Connect Biopharma HoldingsValuation and Risks. We base our valuation on our probability-weighted clinical net present value (NPV) discounted cash flow valuation model. We use a weighted average cost of capital of 16.2% in our discounted cash flow, and an exit multiple of 10.0x our 2036 estimates.Our peak sales estimates assume a 55% probability of success for rademikibart in acute exacerbations in the 15% probability of success for rademikibart in the EU.
Northland Securities
$7.5
Buy
248.84%
Upside
Initiated
07/22/25
TR | OpenAI - 4o
―
Hold
―
Reiterated
04/26/25
Best Analysts Covering Connect Biopharma Holdings
1 Month
xxx
Success Rate
7/13 ratings generated profit
Average Return
-1.33%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.85% of your transactions generating a profit, with an average return of -1.33% per trade.
3 Months
xxx
Success Rate
7/13 ratings generated profit
Average Return
-0.72%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of -0.72% per trade.
1 Year
Success Rate
7/13 ratings generated profit
Average Return
+26.77%
reiterated a buy rating 3 days ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of +26.77% per trade.
2 Years
xxx
Success Rate
8/13 ratings generated profit
Average Return
+54.25%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 61.54% of your transactions generating a profit, with an average return of +54.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CNTB Analyst Recommendation Trends
Rating
Mar 25
Apr 25
Jun 25
Jul 25
Aug 25
Strong Buy
1
1
2
3
5
Buy
0
0
0
0
0
Hold
1
4
3
3
0
Sell
2
1
0
0
0
Strong Sell
0
0
0
0
0
total
4
6
5
6
5
Each month's total comprises the sum of three months' worth of ratings.
CNTB Financial Forecast
CNTB Stock Forecast FAQ
What is CNTB’s average 12-month price target, according to analysts?
Based on analyst ratings, Connect Biopharma Holdings Ltd.’s 12-month average price target is 6.83.
What is CNTB’s upside potential, based on the analysts’ average price target?
Connect Biopharma Holdings Ltd. has 217.67% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CNTB a Buy, Sell or Hold?
Connect Biopharma Holdings Ltd. has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Connect Biopharma Holdings Ltd.’s price target?
The average price target for Connect Biopharma Holdings Ltd. is 6.83. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.50 ,the lowest forecast is $6.00. The average price target represents 217.67% Increase from the current price of $2.15.
The highest analyst price target is $7.50 ,the lowest forecast is $6.00. The average price target represents 217.67% Increase from the current price of $2.15.
What do analysts say about Connect Biopharma Holdings Ltd.?
Connect Biopharma Holdings Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of CNTB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.